Back to the main directory
Press Release
- Nexstim Abps nya aktier har registrerats i handelsregistret by GlobeNewsWire
- Esperion to Report First Quarter 2023 Financial Results May 9, 2023 by GlobeNewsWire
- Dominion Lending Centres Inc. Announces Q1-2023 Earnings Release Date by GlobeNewsWire
- Science 37 Appoints SVP, Erica Prowisor, to Bolster Patient Recruitment Velocity, Diversity by GlobeNewsWire
- AMSC Awarded Contract for U.S. Navy Deployable Mine Countermeasure System by GlobeNewsWire
- Lightbridge Appoints Dr. Scott Holcombe as Vice President of Engineering by GlobeNewsWire
- Harvard Bioscience Announces First Quarter 2023 Financial Results by GlobeNewsWire
- Wejo and Rekor Announce that Wejo has Joined the Rekor Partner Network to Revolutionize Incident Detection and Response Through Real-Time Connected Vehicle Data by GlobeNewsWire
- Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ by GlobeNewsWire
- Powerfleet Sets First Quarter 2023 Conference Call for Tuesday, May 9, 2023 at 8:30 a.m. ET by GlobeNewsWire
- edgeCore 4.5 is Easier, Fluid, and More Powerful Than Ever by GlobeNewsWire
- InnovAge to Announce Fiscal Third Quarter 2023 Financial Results and Host Conference Call Tuesday, May 9, 2023 by GlobeNewsWire
- Lyra Therapeutics Announces Restart of Pivotal Phase 3 ENLIGHTEN II Clinical Trial of LYR-210 in Chronic Rhinosinusitis by GlobeNewsWire
- Voxtur Announces Changes to Board of Directors by GlobeNewsWire
- MAX Power Acquires Large Claim Block Adjoining Raglan West Lithium Camp, Quebec by GlobeNewsWire
- Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000 by GlobeNewsWire
- Purple Biotech Debuts Scientific Advisory Board by GlobeNewsWire
- EQS-News: PAION AG: VERSCHIEBUNG DER VERÖFFENTLICHUNG DES JAHRES- UND KONZERNABSCHLUSSES 2022 by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc by EQS Group AG
- Lion One Reports New High-grade Gold Results at Tuvatu by Newsfile Corp.
- Form 8.3 - The Vanguard Group, Inc.: THG plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc by EQS Group AG
- Valoe received an order for product development and prototyping from a US military and space company. The order will generate monetary value in 2024 if the cooperation continues. by GlobeNewsWire
- Grab to Announce First Quarter 2023 Results on May 18, 2023 by GlobeNewsWire
- FICO Survey: Majority of US Consumers Have Been Contacted by Real-Time-Payment Scammers by BusinessWire
- goeasy Ltd. Announces Timing of First Quarter 2023 Conference Call and Webcast by GlobeNewsWire
- Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ by GlobeNewsWire
- Vaccinex Completes Enrollment in Phase 1b/2 SIGNAL-AD (Alzheimer’s Disease) Study of Pepinemab by GlobeNewsWire
- First Merchants Corporation Announces First Quarter 2023 Earnings Per Share by GlobeNewsWire
- Lakeland Financial Reports Record First Quarter Performance; Balance Sheet Strength Highlights the Quarter by GlobeNewsWire
- Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI® by GlobeNewsWire
- DZS to Report First Quarter 2023 Results on May 8 by GlobeNewsWire
- Erasca Announces Publication of Promising Clinical Data Supporting the Therapeutic Potential of Naporafenib in Combination with Trametinib in NRAS-Mutant Melanoma by GlobeNewsWire
- Cue Biopharma Welcomes Seasoned Pharmaceutical Executive Pamela D. Garzone, Ph.D., to its Board of Directors by GlobeNewsWire
- HTG Provides Update on Drug Discovery Partnering Initiative by GlobeNewsWire
- Old National's 1st Quarter Results Supported by Strong Deposit Franchise, Ample Liquidity, Stable Credit and Expense Discipline by GlobeNewsWire
- Ocuphire Provides Corporate Update and Reiterates Previous Guidance on Clinical Programs by GlobeNewsWire
- iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Boca Raton Regional Hospital by GlobeNewsWire
- TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting by GlobeNewsWire
- NV5 Awarded $16 Million in California Utility Gas Pipeline Design and Support by GlobeNewsWire
- IN8bio Receives FDA Orphan Drug Designation for INB-400/410 for the Treatment of Newly Diagnosed Glioblastoma by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc by EQS Group AG
- EQS-News: POSTPONEMENT OF PUBLICATION OF THE ANNUAL AND CONSOLIDATED FINANCIAL STATEMENTS 2022 by EQS Group AG
- Auburn National Bancorporation, Inc. Reports First Quarter Net Earnings by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc by EQS Group AG
- Keysight Technologies to Host Webcast of Second Quarter Fiscal Year 2023 Earnings Conference Call by BusinessWire
- Valoe sai tilauksen tuotekehityksestä ja prototyypin valmistuksesta yhdysvaltalaiselta militääri- ja avaruusteollisuusyritykseltä. Tilauksen taloudellinen merkitys alkaa näkyä vuonna 2024, mikäli yhteistyö jatkuu. by GlobeNewsWire
- KYOCERA Develops EIA 0201 Size Multilayer Ceramic Capacitor (MLCC) with the Industry’s Highest*1 Capacitance of 10 Microfarads by BusinessWire
- Karooooo to Announce Fourth Quarter and Full Year 2023 Results on May 8, 2023 by BusinessWire